37 related articles for article (PubMed ID: 27906674)
1. Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
Ruggeri E; Frezzato F; Mouawad N; Pizzi M; Scarmozzino F; Capasso G; Trimarco V; Quotti Tubi L; Cellini A; Cavarretta CA; Ruocco V; Serafin A; Angotzi F; Danesin N; Manni S; Facco M; Piazza F; Trentin L; Visentin A
Front Immunol; 2024; 15():1393485. PubMed ID: 38807597
[TBL] [Abstract][Full Text] [Related]
2. Intracellular localization of CK2α as a prognostic factor in invasive breast carcinomas.
Homma MK; Kiko Y; Hashimoto Y; Nagatsuka M; Katagata N; Masui S; Homma Y; Nomizu T
Cancer Sci; 2021 Feb; 112(2):619-628. PubMed ID: 33164285
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle-dependent gene networks for cell proliferation activated by nuclear CK2α complexes.
Homma MK; Nakato R; Niida A; Bando M; Fujiki K; Yokota N; Yamamoto S; Shibata T; Takagi M; Yamaki J; Kozuka-Hata H; Oyama M; Shirahige K; Homma Y
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37907238
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of casein kinase 2 prevents growth of human osteosarcoma.
Takahashi K; Setoguchi T; Tsuru A; Saitoh Y; Nagano S; Ishidou Y; Maeda S; Furukawa T; Komiya S
Oncol Rep; 2017 Feb; 37(2):1141-1147. PubMed ID: 27959425
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase CK2 - diverse roles in cancer cell biology and therapeutic promise.
Trembley JH; Kren BT; Afzal M; Scaria GA; Klein MA; Ahmed K
Mol Cell Biochem; 2023 Apr; 478(4):899-926. PubMed ID: 36114992
[TBL] [Abstract][Full Text] [Related]
6. The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review.
Halloran D; Pandit V; Nohe A
J Dev Biol; 2022 Jul; 10(3):. PubMed ID: 35997395
[TBL] [Abstract][Full Text] [Related]
7. An Integrative Pan-Cancer Analysis of the Prognostic and Immunological Role of Casein Kinase 2 Alpha Protein 1 (CSNK2A1) in Human Cancers: A Study Based on Bioinformatics and Immunohistochemical Analysis.
Wu R; Tang W; Qiu K; Li P; Li Y; Li D; He Z
Int J Gen Med; 2021; 14():6215-6232. PubMed ID: 34621130
[TBL] [Abstract][Full Text] [Related]
8. CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway.
Hussein UK; Ahmed AG; Song Y; Kim KM; Moon YJ; Ahn AR; Park HS; Ahn SJ; Park SH; Kim JR; Jang KY
Cells; 2021 Jul; 10(7):. PubMed ID: 34359939
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase CK2: a potential therapeutic target for diverse human diseases.
Borgo C; D'Amore C; Sarno S; Salvi M; Ruzzene M
Signal Transduct Target Ther; 2021 May; 6(1):183. PubMed ID: 33994545
[TBL] [Abstract][Full Text] [Related]
10. Protein Kinase CK2 in Cancer Energetics.
Silva-Pavez E; Tapia JC
Front Oncol; 2020; 10():893. PubMed ID: 32626654
[TBL] [Abstract][Full Text] [Related]
11. Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors.
Guerra B; Issinger OG
Pharmaceuticals (Basel); 2019 Jan; 12(1):. PubMed ID: 30609679
[TBL] [Abstract][Full Text] [Related]
12. Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival.
Vilardell J; Alcaraz E; Sarró E; Trilla E; Cuadros T; de Torres I; Plana M; Ramón Y Cajal S; Pinna LA; Ruzzene M; Morote J; Meseguer A; Itarte E
Oncotarget; 2018 Jan; 9(5):5736-5751. PubMed ID: 29464030
[TBL] [Abstract][Full Text] [Related]
13. Cancer-type dependent expression of CK2 transcripts.
Chua MMJ; Lee M; Dominguez I
PLoS One; 2017; 12(12):e0188854. PubMed ID: 29206231
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of subcellular migration of CK2α localization from nucleus to sarco(endo)plasmic reticulum in mammalian cardiomyocytes under hyperglycemia.
Bitirim CV; Tuncay E; Turan B
Mol Cell Biochem; 2018 Jun; 443(1-2):25-36. PubMed ID: 29058176
[TBL] [Abstract][Full Text] [Related]
15. CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.
Chua MM; Ortega CE; Sheikh A; Lee M; Abdul-Rassoul H; Hartshorn KL; Dominguez I
Pharmaceuticals (Basel); 2017 Jan; 10(1):. PubMed ID: 28134850
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of the CK2α-subunit correlates with poor prognosis in clear cell renal cell carcinoma.
Rabjerg M; Guerra B; Oliván-Viguera A; Mikkelsen ML; Köhler R; Issinger OG; Marcussen N
Oncotarget; 2017 Jan; 8(1):1613-1627. PubMed ID: 27906674
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
18. Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer.
Kim HM; Jeong I; Kim HJ; Kang SK; Kwon WS; Kim TS; Park KH; Jung M; Soong J; Lin SC; Chung HC; Rha SY
Anticancer Res; 2018 Nov; 38(11):6171-6180. PubMed ID: 30396934
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer.
Lin KY; Tai C; Hsu JC; Li CF; Fang CL; Lai HC; Hseu YC; Lin YF; Uen YH
PLoS One; 2011 Feb; 6(2):e17193. PubMed ID: 21359197
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
